ArticleMedicine2021
Partial response of donafenib as the third-line therapy in metastatic colon cancer: A case report.
Yang Yang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleMedicine2021
Yang Yang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.